GDNF Gene Therapy for Parkinson's Disease
GDNF Gene Therapy for Parkinson's Disease
Active, not recruiting · NCT04167540 · Registry updated 2025-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GDNF Gene Therapy for Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Active, not recruiting | Phase 1 | 2025-09-19 | NCT04167540 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AskBio Inc | 8 |
| Brain Neurotherapy Bio, Inc. | 2 |
| California Institute for Regenerative Medicine (CIRM) | 36 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Ohio State University Medical Center | Columbus | United States | 13 |
| University of California Irvine | Irvine | United States | 30 |
| University of California San Francisco | San Francisco | United States | 1 |